A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients(SUPER-1)

NCT04994288 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

547

Enrollment

OTHER

Sponsor class

Conditions

Type2 Diabetes

Interventions

BIOLOGICAL: Supaglutide injection
OTHER: placebo injection

Sponsor

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.